Sulfanilamide

Sulfanilamide

SCHEMBL5894222

Cl.Nc1ccc(S(N)(=O)=O)cc1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Sulfanilamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 16/20 0.94
CA9 Q16790 14/20 0.94
CA1 P00915 13/20 0.94
CA12 O43570 12/20 0.94
CA14 Q9ULX7 6/20 0.94
CA7 P43166 6/20 0.94
CA6 P23280 4/20 0.94
CA5A P35218 4/20 0.94
CA5B Q9Y2D0 4/20 0.94
TSHR P16473 3/20 0.94
CA4 P22748 3/20 0.94
CA13 Q8N1Q1 2/20 0.94
USP2 O75604 1/20 0.94
TDP1 Q9NUW8 1/20 0.94
AGO2 Q9UKV8 1/20 0.94
HTT P42858 1/20 0.63
LMNA P02545 1/20 0.62
MPO P05164 1/20 0.62
CYP3A4 P08684 1/20 0.62
CYP2C9 P11712 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfanilamide SCHEMBL7624621 1.00 CA2 (0.94) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL740 0.97 CA2 (1.00) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL2798899 0.97 CA2 (1.00) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL31544839 0.97 CA2 (1.00) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL30659052 0.97 CA2 (1.00) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL8030126 0.94 CA2 (0.94) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL22501553 0.94 CA2 (0.94) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL19210078 0.94 CA2 (0.94) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL3273308 0.94 CA2 (0.94) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL1155220 0.94 CA2 (0.94) CA2CA9CA1CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118275363-A Method and device for online measurement of concentration of atmospheric nitric acid 中国科学院化学研究所 2024-07-02 CN claimed
CN-117105825-A Synthesis method of celecoxib intermediate p-hydrazino benzenesulfonamide hydrochloride 济南大学 2023-11-24 CN claimed
CN-116606231-A P-sulfonamide phenylhydrazine hydrochloride and preparation method thereof 河北冀衡药业股份有限公司 2023-08-18 CN claimed
CN-113218895-B Detection system and method for determining total nitrogen content in water 苏州微湃医疗科技有限公司 2023-04-07 CN claimed
CN-110872242-B Synthesis method of celecoxib intermediate p-hydrazino benzenesulfonamide hydrochloride 湖南方盛制药股份有限公司 2022-03-29 CN claimed
CN-109828089-B DBN-BP-based water quality parameter nitrous acid nitrogen online prediction method 仲恺农业工程学院 2022-01-18 CN claimed
CN-110183684-B Modified oil shale semicoke, preparation method thereof and application thereof in high polymer material 烟台佳合高分子材料有限公司 2021-10-15 CN claimed
CN-113336680-A Environment-friendly technological synthesis method of sulfanilamide 寿光永康化学工业有限公司 2021-09-03 CN claimed
CN-113218895-A Detection system and method for determining total nitrogen content in water 苏州微湃医疗科技有限公司 2021-08-06 CN claimed
CN-110872242-A Synthesis method of celecoxib intermediate p-hydrazino benzenesulfonamide hydrochloride 湖南方盛制药股份有限公司 2020-03-10 CN claimed
CN-105189506-A Compounds and compositions for the treatment of parasitic diseases NOVARTIS AG 2015-12-23 CN claimed
JP-10218856-A None JP disclosed
CN-116606231-B P-sulfonamide phenylhydrazine hydrochloride and preparation method thereof 河北冀衡药业股份有限公司 2025-08-12 CN disclosed
CN-118275363-A Method and device for online measurement of concentration of atmospheric nitric acid 中国科学院化学研究所 2024-07-02 CN disclosed
CN-117653788-A Method for reducing calcification of bioprosthetic tissue and bioprosthetic tissue 上海微创心通医疗科技有限公司 2024-03-08 CN disclosed
EP-1009738-A1 SUBSTITUTED OXINDOLE DERIVATIVES AS PROTEIN TYROSINE KINASE AND AS PROTEIN SERINE/THREONINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 2000-06-21 EP disclosed
WO-1999015500-A1 SUBSTITUTED OXINDOLE DERIVATIVES AS PROTEIN TYROSINE KINASE AND AS PROTEIN SERINE/THREONINE KINASE INHIBITORS GLAXO GROUP LIMITED (GB) 1999-04-01 WO disclosed
JP-H10218856-A PRODUCTION OF 4-SULFONAMIDOPHENYLHYDRAZINE HYDROCHLORIDE SUMIKA FINE CHEM KK 1998-08-18 JP disclosed
EP-0196091-B1 METHOD OF PROCESSING LIGHT-SENSITIVE SILVER HALIDE COLOR PHOTOGRAPHIC MATERIAL KONICA CORPORATION (JP) 1992-10-28 EP disclosed
US-4863837-A Method of processing light-sensitive silver halide color photographic material comprising combinations of two different sequestering agents and a sensitizing dye KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1989-09-05 US disclosed